Follow
E Rutgers
E Rutgers
hoogleraar chirurgische oncologie UvA
Verified email at nki.nl
Title
Cited by
Cited by
Year
A gene-expression signature as a predictor of survival in breast cancer
MJ Van De Vijver, YD He, LJ Van't Veer, H Dai, AAM Hart, DW Voskuil, ...
New England Journal of Medicine 347 (25), 1999-2009, 2002
74522002
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
36412013
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
M Kriege, CTM Brekelmans, C Boetes, PE Besnard, HM Zonderland, ...
New England Journal of Medicine 351 (5), 427-437, 2004
20632004
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
19292015
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 379 (9814), 432-444, 2012
18872012
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
18482009
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 26, v8-v30, 2015
17292015
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
15192016
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …
P McGale, C Correa, D Cutter, F Duane, M Ewertz, R Gray, G Mannu, ...
The Lancet 383 (9935), 2127-35, 2014
15092014
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority …
M Donker, G van Tienhoven, ME Straver, P Meijnen, CJH van de Velde, ...
The lancet oncology 15 (12), 1303-1310, 2014
14812014
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
14432006
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ...
Nature 551 (7678), 92-94, 2017
10162017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
10022017
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized …
N Bijker, P Meijnen, JL Peterse, J Bogaerts, I Van Hoorebeeck, J Julien, ...
Journal of clinical oncology 24 (21), 3381-3387, 2006
6882006
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
6582018
Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial
S Litière, G Werutsky, IS Fentiman, E Rutgers, MR Christiaens, ...
The lancet oncology 13 (4), 412-419, 2012
5772012
Prediction of breast cancer risk based on profiling with common genetic variants
N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ...
JNCI: Journal of the National Cancer Institute 107 (5), 2015
5722015
Micrometastases or isolated tumor cells and the outcome of breast cancer
M De Boer, CHM Van Deurzen, JAAM Van Dijck, GF Borm, PJ Van Diest, ...
New England Journal of Medicine 361 (7), 653-663, 2009
5592009
Clinical application of the 70-gene profile: the MINDACT trial
F Cardoso, L Van't Veer, E Rutgers, S Loi, S Mook, MJ Piccart-Gebhart
Journal of clinical oncology 26 (5), 729-735, 2008
5522008
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1353-1361, 2015
5272015
The system can't perform the operation now. Try again later.
Articles 1–20